Investors

You heard it here first.

 
 
 

Our news

Bringing you the latest!

Investors

MedinCell has launched a COVID-19 research initiative based on its experience to formulate long-acting injectable Ivermectin

Corporate - Investors

6 April 2020

Publication of the activity report and financial information for the first half-year (April – Sept. 2019)

Investors

3 December 2019

MedinCell partners to address the untapped financial potential in Animal Health

Investors

28 August 2019

LAI antipsychotic using MedinCell’s technology receives FDA IND clearance to initiate clinical activities

Corporate - Investors

26 August 2019

 
 

CONTACT

  • This field is for validation purposes and should be left unchanged.